NASDAQ Losers: Galena Biopharma Inc (NASDAQ:GALE), Jive Software (NASDAQ:JIVE), Sinclair Broadcast Group, Inc. (NASDAQ:SBGI), Ventrus Biosciences Inc (NASDAQ:VTUS)

TheStreet Quant Ratings rates Galena Biopharma Inc (NASDAQ:GALE) as a sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and feeble growth in its earnings per share. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $5.22 in last trading session, and closed at $4.34, trading in the range of $4.26 – $5.30. The stock showed a positive weekly performance of 10.60%.

Jive Software Inc (NASDAQ:JIVE) issued its quarterly earnings data on Tuesday. The company reported ($0.16) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.16), Analyst Ratings News reports. The company had revenue of $39.30 million for the quarter, compared to the consensus estimate of $39.21 million. During the same quarter in the previous year, the company posted ($0.14) earnings per share. The company’s revenue for the quarter was up 20.9% on a year-over-year basis. Jive Software updated its Q1 guidance to ($0.13)-($0.11) EPS and its FY14 guidance to ($0.46)-($0.39) EPS. Jive Software Inc (NASDAQ:JIVE) shares closed at $7.20 on last trade day, by losing -18.83%. Stock 52 week range is $7.20 – $18.48. Company’s market capitalization is $495.08 million.

Sinclair Broadcast Group, Inc. (NASDAQ:SBGI) shares traded down 5.8% during trading on Wednesday following a dissappointing earnings announcement, American Banking & Market News reports. The company traded as low as $25.44 and last traded at $26.25, with a volume of 4,864,821 shares trading hands. The stock had previously closed at $27.86. Sinclair Broadcast Group, Inc. (NASDAQ:SBGI) stock decreased -5.46% and finished the last session at $26.34. The EPS of the stock remained 1.36. Company’s market capitalization is $2.64 billion.

Ventrus Biosciences Inc (NASDAQ:VTUS) was downgraded by stock analysts at Cantor Fitzgerald from a “buy” rating to a “hold” rating in a report issued on Wednesday, TheFlyOnTheWall.com reports. Ventrus Biosciences Inc (NASDAQ:VTUS) stock opened at $1.51 in last trading session and closed at $1.62. The 52 week range of the stock is $1.47 – $4.69 and the day range was $1.47 – $1.78.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *